Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.31 AUD | 0.00% | 0.00% | +29.17% |
Apr. 02 | Artrya Signs Commercial Agreement for Heart Disease Diagnostic Technology; Shares Up 8% | MT |
Mar. 12 | Artrya Gears Up for US Launch After Tanner Health System Partnership | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.28M 26.45M |
---|---|---|---|---|---|
Net income 2022 | -17M -26.03M | Net income 2023 | -11M -16.84M | EV / Sales 2022 | - |
Net cash position 2022 | 34.19M 52.34M | Net cash position 2023 | 19.19M 29.38M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.51
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.29% |
Current month | +5.08% | ||
1 month | +14.81% | ||
3 months | +40.91% | ||
6 months | +55.00% | ||
Current year | +29.17% |
Managers | Title | Age | Since |
---|---|---|---|
Mathew Regan
CEO | Chief Executive Officer | - | 23-03-26 |
Mark Wainwright
DFI | Director of Finance/CFO | - | 21-08-31 |
Jacob Agris
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacque Sokolov
BRD | Director/Board Member | 69 | 22-07-31 |
Chairman | 70 | 21-01-31 | |
Catherine Hill
BRD | Director/Board Member | 65 | 23-02-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.31 | 0.00% | 5,148 |
24-04-24 | 0.31 | +1.64% | 50,126 |
24-04-23 | 0.305 | -4.69% | 12,500 |
24-04-22 | 0.32 | +3.23% | 13,543 |
24-04-19 | 0.31 | +6.90% | 52,117 |
Delayed Quote Australian S.E., April 25, 2024 at 09:26 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+29.17% | 15.91M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B | |
-15.34% | 1.03B |
- Stock Market
- Equities
- AYA Stock